Posted in | News | Consumer Robotics

GeckoSystems Reports Final Negotiations for Licensing of Mobile Robot Solutions for Safety, Security and Service

GeckoSystems Intl. Corp. has announced that final negotiations for licensing of their "Mobile Robot Solutions for Safety, Security and Service(tm)" are ongoing. This first joint venture and licensing agreement has been long sought by the management of GeckoSystems as irrefutable proof of the benefit and "value proposition" of their many years of R&D, testing, and marketing.

This party understands the breadth of the Mobile Service Robots (MSR's) market and is motivated to establish itself as the dominant regional developer, manufacturer, and marketer. In addition, the prospective licensee has expressed intent to develop and market GeckoSystems' numerous product concepts such as the ChairBot(tm), SecurityBot(tm), GeckoNED(tm), and GeckoSuperSentinel(tm).

"Over the last several years, we have entered into dozens of non-disclosure agreements and many Memorandums Of Understanding (MOU's), all in good faith, but for various reasons we have been unable to finalize a licensing agreement and initiate the technology transfers to enable production. Due to the sincerity of this party's interest and the depth of their business acumen, I am the most confident I have ever been that we will soon be announcing a 'done deal' and realizing our first licensing revenues before the end of our fiscal year," reflected Martin Spencer , President/CEO, GeckoSystems Intl. Corp.

GeckoSystems' AI mobile robot solutions are unique in that they are portable and extensible, enabling ready migration and usage to a large number of MSR applications and marketplaces. Using GeckoSystems' proprietary technology, licensees are able to develop new products quickly and with reduced R&D cost, giving them a competitive edge that is "fast to market" when entering new markets. In addition, GeckoSystems' robust hardware and software architecture makes applications based on their technology "obsolescence proof" because new technology and/or cost reduction can be integrated on a modular basis as it develops.

"While we remain focused on our Pacific Rim business development activities, we now have new, ongoing discussions in several EU and Mediterranean countries. These discussions are primarily in the areas of commercial security and professional healthcare. We generally get favorable reactions and heightened interest due to our willingness to share risk in the proposed joint ventures," commented Spencer.

In 2010 the AI navigation software developed for and used on the CareBot(tm) was migrated and with limited, additional R&D; the company was able to create the SafePath(tm) "collision free" power wheelchair upgrade. This migration proved the extensible and portable nature of GeckoSystems' AI mobile robot architecture and its ability to accelerate development of additional MSR applications. This is why GeckoSystems is gaining worldwide recognition in the robotics field. Research and Markets recently identified GeckoSystems as one of eight "key market players" along side Honda, iRobot, Sony, Toyota, and others. The company is delighted to receive this global recognition.

GeckoSystems' Japanese associate, ZMP has graciously hosted several demonstrations of the company's technologies in their office in Tokyo using the BaseBot that was shipped to them a year ago. The BaseBot demonstrates SafePath, the world's first and only AI navigation system capable of "sense and avoid" of not only stationary obstacles, but also dynamic obstacles, while seeking the user's desired destination.

ZMP's evaluation of the BaseBot was very favorable. ZMP of Japan, a long established vendor of robotic research platforms, has confirmed that the navigation system used in the BaseBot (and hence CareBot, etc.) is "sophisticated" and "fully developed."

Due to these recent demonstrations, GeckoSystems is in ongoing discussions concerning joint ventures and/or licensing of their proprietary technologies to develop products in the security and healthcare sectors in China, Japan, Taiwan, and the EU and one Mediterranean country. There are world wide demographic changes that are expanding opportunities in the health care market globally, but in the Pacific Rim, EU and Mediterranean, the need is urgent and GeckoSystems complete suite of mobile robot solutions offers a distinct competitive advantage because of being "fast to market" and having a compelling "value proposition."

In March of 2015 the Japanese national health care plan will begin to cover robotic personal assistance applications at a rate of 90%. Because of the demographic issues outlined in the report below, a CareBot type personal robot designed to help people live independently in their own home as long as possible will be in high demand. GeckoSystems believes that no economically viable solution can be developed for this market by that March 2015 date without using their technology.

"We expect these seminal, final JV negotiations to be favorably consummated at any time. I remain personally grateful for our 1300+ stockholders' loyal support and look forward to their being rewarded with a satisfying ROI," concluded Spencer.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    GeckoSystems Intl. Corp.. (2022, July 12). GeckoSystems Reports Final Negotiations for Licensing of Mobile Robot Solutions for Safety, Security and Service. AZoRobotics. Retrieved on May 24, 2024 from

  • MLA

    GeckoSystems Intl. Corp.. "GeckoSystems Reports Final Negotiations for Licensing of Mobile Robot Solutions for Safety, Security and Service". AZoRobotics. 24 May 2024. <>.

  • Chicago

    GeckoSystems Intl. Corp.. "GeckoSystems Reports Final Negotiations for Licensing of Mobile Robot Solutions for Safety, Security and Service". AZoRobotics. (accessed May 24, 2024).

  • Harvard

    GeckoSystems Intl. Corp.. 2022. GeckoSystems Reports Final Negotiations for Licensing of Mobile Robot Solutions for Safety, Security and Service. AZoRobotics, viewed 24 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.